AdaptVac Company

AdaptVac is a joint-venture between ExpreS2ion Biotech and University of Copenhagen spin-out NextGen Vaccines.
Technology: Atrificial Vectors and Immune Cells
Industry: Atrificial Vectors and Immune Cells
Headquarters: Hørsholm, Hovedstaden, Denmark
Founded Date: 2017-01-01
Employees Number: 1-10
Funding Status: N/A
Investors Number: 1
Total Funding: 119126
Last Funding Date: 2019-10-17
Last Funding Type: Grant

Visit Website
info@adaptvac.com
Register and Claim Ownership